or Try an Advanced Search...

    ETF Components for XBI - SPDR S&P Biotech ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    ALPN A 0.02 1.85
    RVMD A 0.03 1.26
    EXAS B -3.43 1.20
    BMRN A -0.58 1.19
    CYTK D -0.64 1.18
    CRNX A 0.00 1.16
    EXEL A -0.22 1.15
    NTRA A -2.07 1.14
    CERE B -0.05 1.13
    MRNA A 1.01 1.13
    KRYS A -2.48 1.11
    ALNY F 0.89 1.10
    AMGN D 1.11 1.09
    IMVT F -2.08 1.08
    VRTX C 0.60 1.07
    UTHR A -0.11 1.07
    NBIX C -0.44 1.07
    INSM D -2.22 1.06
    GERN A 2.01 1.06
    SRPT D -0.31 1.06
    IONS D 0.25 1.06
    VKTX B -2.47 1.06
    BPMC A -0.53 1.05
    REGN C 0.34 1.04
    DYN B -0.04 1.04
    MDGL D -2.79 1.03
    RYTM D 0.63 1.03
    HALO D 0.82 1.03
    IDYA D -0.69 1.02
    ARQT B -2.43 1.02
    ABBV C 0.60 1.02
    GILD F 0.59 1.01
    INCY F -0.38 1.00
    VCEL B -1.14 1.00
    RCKT D -0.60 0.98
    BBIO F -0.64 0.98
    BIIB F 0.36 0.98
    DVAX D 2.91 0.98
    IRWD F 2.89 0.98
    SNDX D 1.37 0.97
    SWTX D -1.01 0.96
    PCVX D 0.58 0.96
    FOLD D 2.61 0.96
    TGTX D -2.79 0.94
    RARE D -0.15 0.94
    APLS F -1.33 0.94
    CPRX A 1.11 0.93
    DNLI F -0.66 0.92
    CLDX D -1.51 0.91
    VERA D -1.87 0.91
    PTCT F 0.97 0.91
    ALKS F -0.25 0.91
    BCRX F -0.89 0.89
    KYMR D -0.37 0.88
    ARDX D 0.39 0.87
    TWST D 0.74 0.86
    INBX C 0.29 0.86
    ACLX D -2.37 0.86
    NUVL D 1.24 0.86
    KROS D 0.48 0.85
    IOVA D -2.30 0.85
    CRSP F 0.55 0.83
    NTLA F 0.19 0.82
    ACAD F -0.94 0.82
    NVAX F 1.80 0.82
    ALT D -1.60 0.81
    ARWR F -1.50 0.80
    AKRO F 0.73 0.79
    PRTA F -0.24 0.79
    AGIO B 2.21 0.78
    MIRM F -0.21 0.78
    PTGX D -0.16 0.77
    BEAM F -0.12 0.77
    VRDN F 0.46 0.76
    RXRX F -1.76 0.76
    SAGE F 3.03 0.75
    MORF F -0.22 0.75
    VCYT F -0.31 0.72
    MGNX B -2.55 0.72
    CABA F -1.57 0.71
    KURA D 0.51 0.71
    CCCC D 0.43 0.70
    BMEA F -0.54 0.70
    RCUS F -0.27 0.66
    RNA A 0.69 0.59
    SRRK D 0.93 0.59
    EDIT F -0.90 0.58
    MYGN D -0.05 0.58
    ARCT F -0.15 0.58
    COGT D 2.57 0.56
    REPL F -2.01 0.56
    ETNB F -0.45 0.53
    XNCR F -2.06 0.53
    ADMA A -0.48 0.52
    FDMT D 2.34 0.51
    SANA D -0.91 0.51
    FATE D -3.08 0.48
    CDMO F -1.07 0.47
    ZNTL F 2.55 0.47
    TVTX F 0.17 0.45
    VIR F 0.38 0.45
    DCPH D -0.28 0.40
    RGNX F -0.25 0.39
    OLMA F -0.20 0.39
    IRON F -2.86 0.38
    VERV F 0.75 0.38
    NRIX A 0.17 0.38
    RLAY F 1.15 0.38
    MNKD D 1.72 0.36
    DAWN B -2.10 0.35
    CDNA F 1.49 0.35
    ALLO F 1.16 0.34
    AVXL F -3.42 0.34
    KNSA D 0.50 0.30
    SMMT D -1.85 0.28
    CRBU F 1.28 0.27
    ANAB D 3.23 0.24
    MDXG F -0.24 0.22
    CGEM B -1.33 0.21
    ALEC F 1.18 0.18
    MRSN D -0.60 0.17
    SPRY B -0.24 0.13
    ORIC D -3.36 0.13
    VYGR F 0.00 0.12
    RCEL F -1.35 0.06

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Biotechnology Medicine Cancer Life Sciences Clinical Medicine Biology Immune System Clinical Development Immunology Solid Tumors Disease Antibodies Organ Systems Monoclonal Antibodies Treatment Of Cancer Autoimmune Disease Monoclonal Antibody Enzymes Genetics
    Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices

    Recent News for SPDR S&P Biotech ETF & its Holdings

    Date Stock Title
    Apr 19 REGN Regeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Caution
    Apr 19 GILD FDA requires labeling changes to CAR-T cell therapies to reflect cancer risk
    Apr 18 GILD US FDA mandates label updates on CAR-T cancer therapies
    Apr 18 GILD Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know
    Apr 18 FATE Fate Therapeutics files to sell 3.64M shares for holders
    Apr 18 VKTX Viking Therapeutics: An Oral Weight Loss Drug With More Data Ahead
    Apr 18 ABBV Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson's Disease Study
    Apr 18 ALLO To The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation
    Apr 18 RNA To The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation
    Apr 18 FDMT To The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation
    Apr 18 CRBU Caribou Biosciences: 2 Clinical Data Updates In 2024 Could Bring Value
    Apr 18 REGN Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success
    Apr 18 ABBV AbbVie Q1 Earnings Preview: No Repeat Of Last Year's Q1 Disappointment
    Apr 18 GILD Gilead Sciences Publishes 2023 ESG Impact Report
    Apr 18 TGTX TG Therapeutics wins VA contract for Briumvi
    Apr 18 HALO Halozyme Therapeutics (HALO) is an Incredible Growth Stock: 3 Reasons Why
    Apr 18 ABBV Heard on the Street: AbbVie’s Bet on a Neuroscience Drug Maker Just Got Better
    Apr 18 CERE Heard on the Street: AbbVie’s Bet on a Neuroscience Drug Maker Just Got Better
    Apr 18 HALO Halozyme Therapeutics (HALO) Upgraded to Buy: Here's What You Should Know
    Apr 18 SAGE Sage (SAGE) Down 20% on Parkinson's Study Missing Primary Goal
    The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
    Index Fund Stock Market Index Biotechnology S&P Total Market Index ( Biotechnology Segment
    Back to the Main XBI Page...